Osteoporosis Clinical Trials

Showing 401-420 of 595 trials

A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED)

NCT00770159

This study will assess the safety, tolerability, PK, and PD of a once weekly dose of MK0822 in healthy postmenopausal women.

Osteoporosis

Merck Sharp & Dohme LLC78 participantsStarted Nov 2004

COMPLETEDPhase 3

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

NCT00048074

This study will assess the efficacy and safety of intravenous administration of Bonviva regimens in women with post-menopausal osteoporosis, compared to oral daily administration. Patients will also receive daily supplementation with vitamin D and calcium. The anticipated time of study treatment is 2+ years, and the target sample size is 500+ individuals.

Post Menopausal Osteoporosis

Hoffmann-La Roche1,395 participantsStarted Jun 2002

Little Rock, Arkansas, United States • Irvine, California, United States • Rancho Mirage, California, United States +61 more locations

A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED)

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

Related Searches

Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women

MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)

Development of Non-invasive Method for Quantifying Vitamin D Levels in the Body Using Spectroscopy

Electromagnetic Treatment For Bone Loss After Forearm Fracture

Osteoporosis Disease Management Demonstration Project (0000-040)

Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women

Systemic Vitamin D Supplementation in Dental Implants Patients

Active Rehabilitation in Osteoporotic Patients

Changes in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a "Drug Holiday" From Bisphosphonates

Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women

Bone Microarchitecture in Women With and Without Fracture

Mg Induced Changes From Day 0 to Day 28 on Serum and Urine Bone Metabolic Parameters in 70 y Old Females (no 50).

Bone Loss After Laparoscopic Roux-en-Y Gastric Bypass

A Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) in Healthy Volunteers

Vitamin D Supplementation in Postmenopausal Women With Osteoporosis: Proposal of a Therapeutic Regimen in Practice

Zoledronic Acid for Osteoporosis in the Elderly

Osteoporosis Prevention After Heart Transplant

GIOP Prevention Among People With Rheumatoid Arthritis